These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 15812200

  • 1. The role of ximelagatran in the treatment of venous thromboembolism.
    Schulman S.
    Pathophysiol Haemost Thromb; 2005; 34 Suppl 1():18-24. PubMed ID: 15812200
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.
    Colwell C, Mouret P.
    Semin Vasc Med; 2005 Aug; 5(3):266-75. PubMed ID: 16123914
    [Abstract] [Full Text] [Related]

  • 4. Prognostic factors for recurrence of venous thromboembolism (VTE) or bleeding during long-term secondary prevention of VTE with ximelagatran.
    Eriksson H, Lundström T, Wåhlander K, Clason SB, Schulman S, THRIVE III Investigators.
    Thromb Haemost; 2005 Sep; 94(3):522-7. PubMed ID: 16268466
    [Abstract] [Full Text] [Related]

  • 5. New anticoagulants for treatment of venous thromboembolism.
    Weitz JI.
    Circulation; 2004 Aug 31; 110(9 Suppl 1):I19-26. PubMed ID: 15339877
    [Abstract] [Full Text] [Related]

  • 6. Ximelagatran: a new oral anticoagulant.
    Hrebickova L, Nawarskas JJ, Anderson JR.
    Heart Dis; 2003 Aug 31; 5(6):397-408. PubMed ID: 14633322
    [Abstract] [Full Text] [Related]

  • 7. Treatment of venous thromboembolism with the oral thrombin inhibitor, ximelagatran.
    Harenberg J, Ingrid J, Tivadar F.
    Isr Med Assoc J; 2002 Nov 31; 4(11):1003-5. PubMed ID: 12489490
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Secondary prevention of venous thromboembolism with the oral direct thrombin inhibitor ximelagatran.
    Schulman S, Wåhlander K, Lundström T, Clason SB, Eriksson H, THRIVE III Investigators.
    N Engl J Med; 2003 Oct 30; 349(18):1713-21. PubMed ID: 14585939
    [Abstract] [Full Text] [Related]

  • 10. Ximelagatran vs low-molecular-weight heparin and warfarin for the treatment of deep vein thrombosis: a randomized trial.
    Fiessinger JN, Huisman MV, Davidson BL, Bounameaux H, Francis CW, Eriksson H, Lundström T, Berkowitz SD, Nyström P, Thorsén M, Ginsberg JS, THRIVE Treatment Study Investigators.
    JAMA; 2005 Feb 09; 293(6):681-9. PubMed ID: 15701909
    [Abstract] [Full Text] [Related]

  • 11. Initial treatment of venous thromboembolism.
    Becattini C, Agnelli G, Emmerich J, Bura A, Weitz JI.
    Thromb Haemost; 2006 Sep 09; 96(3):242-50. PubMed ID: 16953263
    [Abstract] [Full Text] [Related]

  • 12. [Ximelagatran for treatment of venous thromboembolism].
    Harenberg J, Fenyvesi T, Jörg I.
    Hamostaseologie; 2002 Aug 09; 22(3):25-9. PubMed ID: 12215758
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Risk of recurrent venous thromboembolism or bleeding in relation to thrombophilic risk factors in patients receiving ximelagatran or placebo for long-term secondary prevention of venous thromboembolism.
    Wåhlander K, Eriksson H, Lundström T, Billing Clason S, Wall U, Nyström P, Wessman P, Schulman S, THRIVE III Investigators.
    Br J Haematol; 2006 Apr 09; 133(1):68-77. PubMed ID: 16512831
    [Abstract] [Full Text] [Related]

  • 15. Ximelagatran for the secondary prevention of venous thromboembolism: a complementary follow-up analysis of the THRIVE III study.
    Schulman S, Lundström T, Wålander K, Billing Clason S, Eriksson H.
    Thromb Haemost; 2005 Oct 09; 94(4):820-4. PubMed ID: 16270637
    [Abstract] [Full Text] [Related]

  • 16. Ximelagatran: an oral direct thrombin inhibitor.
    Dager WE, Vondracek TG, McIntosh BA, Nutescu EA.
    Ann Pharmacother; 2004 Nov 09; 38(11):1881-97. PubMed ID: 15383641
    [Abstract] [Full Text] [Related]

  • 17. Oral anticoagulant therapy in venous thromboembolism.
    Cosmi B, Palareti G.
    Semin Vasc Med; 2003 Aug 09; 3(3):303-14. PubMed ID: 15199464
    [Abstract] [Full Text] [Related]

  • 18. Heparin and low-molecular-weight heparin therapy for venous thromboembolism: will unfractionated heparin survive?
    Hull RD, Pineo GF.
    Semin Thromb Hemost; 2004 Feb 09; 30 Suppl 1():11-23. PubMed ID: 15085462
    [Abstract] [Full Text] [Related]

  • 19. [New treatments for venous thromboembolic disease].
    Combe S, Büller HR.
    J Mal Vasc; 2011 Dec 09; 36 Suppl 1():S16-9. PubMed ID: 22177764
    [Abstract] [Full Text] [Related]

  • 20. Melagatran and ximelagatran: new drug. No real simplification of anticoagulant therapy.
    Prescrire Int; 2005 Aug 09; 14(78):127-32. PubMed ID: 16106594
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.